ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
48 announcements with these filters
Niva Bupa Health Insurance scheduled its 18th AGM for August 12, 2026. The meeting will address financial statements, auditor appointments, and director remunerations via video conferencing.
ICRA Limited assigned an issuer rating of [ICRA]AAA(Stable) to Niva Bupa Health Insurance. This top-tier investment grade rating reflects strong creditworthiness and stable outlook.
Niva Bupa received a ₹22.12 Crore GST refund sanction order. The tax litigation, concerning input tax credit from 2017-2022, was resolved in the company's favor.
Niva Bupa appointed Mr. Ashwani Bhatia as Chairperson following Mr. Milind Barve's resignation due to health reasons. The leadership transition ensures continuity in board governance.
Niva Bupa Health Insurance filed its Annual Secretarial Compliance Report for FY2025-26. The auditor confirmed compliance with SEBI regulations, noting no fresh penalties during the review period.
Niva Bupa reported strong Q4 FY26 results with PAT growing 90% YoY to ₹366cr for the full year. Strategy focuses on multichannel distribution and digital growth.
Niva Bupa Health Insurance reported FY26 Net Profit of ₹13,078 lakhs on Gross Premiums of ₹8,58,592 lakhs. Focus remains on retail health and solvency management.
Niva Bupa elevated Ankur Kharbanda to Deputy CEO while Ms. Penelope Dudley and Mr. Carlos Jaureguizar Ruiz-Jarabo resigned. The board also approved 12,251,268 ESOP grants.
Niva Bupa reported ₹366 Crore PAT for FY26, representing 80% year-on-year growth. Gross Written Premium reached ₹8,586 Crore as market share improved to 10.1%.
Niva Bupa achieved 27.4% GWP growth to ₹9,433 Cr and 80.4% PAT growth to ₹366.1 Cr (IFRS) in FY26, driven by retail health expansion and improved efficiencies.
Niva Bupa reported stellar FY26 performance with GWP of ₹9,433 crore and PAT of ₹366 crore (IFRS). Strategy focuses on multi-channel distribution, digital automation, and LTV-based underwriting to drive profitability.
Niva Bupa Health Insurance Company Ltd reported revenue from operations of ₹2,302 Cr (+37.7% YoY) and net profit of ₹345.1 Cr (+67.4% YoY) for Q4 FY26.
Niva Bupa Health Insurance reported a net profit of ₹130.78 Crore for FY26. The board approved these results following its meeting on May 08, 2026.
Niva Bupa Health Insurance Company Limited will hold a Board meeting on May 08, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until May 10, 2026.
Niva Bupa Health Insurance Company Limited has scheduled a board meeting for May 8, 2026, to approve audited standalone annual financial results for the year ended March 31, 2026. Consequently, the trading window for designated persons remains closed until May 10, 2026.
Niva Bupa Health Insurance Company Limited has scheduled a Board Meeting on May 08, 2026. The board will consider audited financial results for the quarter and year ended March 31, 2026. The trading window remains closed until May 10, 2026.
Niva Bupa Health Insurance Company Ltd received IRDAI approval for the transfer of up to 14,62,02,091 equity shares by its existing investor, Fettle Tone LLP. The approval was granted under Section 6A of the Insurance Act, 1938. This regulatory clearance facilitates a significant shareholding transfer within the company's investor base.
Niva Bupa Health Insurance Company Ltd reported a net loss of ₹87.6 Cr for Q3 FY26.